世界のシクロオキシゲナーゼ2阻害剤市場2020-2026:疾患別(変形性関節症、関節リウマチ、その他)、種類別、投与経路別、エンドユーザー別、流通チャンネル別、地域別

◆英語タイトル:Global Cyclooxygenase2 inhibitor Market Size study, by Indication (Osteoarthritis, Rheumatoid arthritis and Others), Types (Selective cox 2 inhibitor and Non-selective cox 2 inhibitor), Route of Administration (Oral, parenteral and Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) and Regional Forecasts 2020-2026
◆商品コード:BZW20JL136
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年5月1日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、英国、ドイツ、フランス、中国、インド、日本、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥656,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、シクロオキシゲナーゼ2阻害剤の世界市場について調査・分析し、エグゼクティブサマリー、市場定義・範囲、市場動向、市場分析、疾患別(変形性関節症、関節リウマチ、その他)分析、種類別分析、投与経路別分析、エンドユーザー別分析、地域別分析、競争状況、調査プロセスなどを含め、以下の構成でご提供いたします。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・市場分析
・シクロオキシゲナーゼ2阻害剤の世界市場規模:疾患別(変形性関節症、関節リウマチ、その他)
・シクロオキシゲナーゼ2阻害剤の世界市場規模:種類別
・シクロオキシゲナーゼ2阻害剤の世界市場規模:投与経路別
・シクロオキシゲナーゼ2阻害剤の世界市場規模:エンドユーザー別
・シクロオキシゲナーゼ2阻害剤の世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Cyclooxygenase2 inhibitor Market is valued approximately USD XX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2019-2026. Cyclooxygenase2 inhibitor also known as COX-2 inhibitor, is a nonsteroidal anti-inflammatory drug used to relieve pain and inflammation. Cyclooxygenase-2 inhibitors are being studied in the prevention of colon polyps, and as anticancer drugs. Factors such as rising awareness of the condition, high acceptance rate of cox 2 inhibitors, such as painkillers, are responsible for the development of the global market for cyclooxygenase 2 inhibitors. In addition, the growing prevalence of chronic diseases such as rheumatoid arthritis may also fuel this demand development. For instance, rheumatoid arthritis is a chronic disease affecting over 1.3 million Americans and as much as 1% of the worldwide population in 2018. However, safety issues and severe side effects of cox 2 inhibitors can restrain the growth of this market.

The regional analysis of Coronavirus Diagnostics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Due to increasing awareness of chronic disease diagnosis and high prevalence, Asia-Pacific is projected to account for the largest market share for cyclooxygenase 2 inhibitor market in the coming years. Europe is considered to hold promising opportunities for development in the coming years, while North America is considered to lead the rise due to global players’ focus on emerging technologies.

Major market player included in this report are:
Pfizer Inc.
Bayer AG
Novartis AG
Sabinsa
Cadila Pharmaceuticals
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Alembic Pharmaceuticals Limited
Aurobindo Pharma
Cipla Inc.
Torrent Pharmaceuticals Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Indication:
Osteoarthritis
Rheumatoid arthritis
Others
By Type:
Selective cox 2 inhibitor
Non-selective cox 2 inhibitor
By Route of Administration:
Oral
Parenteral
Others
By End-Users:
Hospitals
Specialty Clinics
Others
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017, 2018
Base year – 20198
Forecast period – 2020 to 2026

Target Audience of the Global Cyclooxygenase2 inhibitor Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2026 (USD Billion)
1.2.1. Global Cyclooxygenase2 inhibitor Market, by Region, 2018-2026 (USD Billion)
1.2.2. Global Cyclooxygenase2 inhibitor Market, by Indication, 2018-2026 (USD Billion)
1.2.3. Global Cyclooxygenase2 inhibitor Market, by Route of Administration, 2018-2026 (USD Billion)
1.2.4. Global Cyclooxygenase2 inhibitor Market, by End-Users, 2018-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cyclooxygenase2 inhibitor Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cyclooxygenase2 inhibitor Market Dynamics
3.1. Global Cyclooxygenase2 inhibitor Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Cyclooxygenase2 inhibitor Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cyclooxygenase2 inhibitor Market, by Indication
5.1. Market Snapshot
5.2. Global Cyclooxygenase2 inhibitor Market by Indication, Performance – Potential Analysis
5.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by Indication 2016-2026 (USD Billion)
5.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
5.4.1. Osteoarthritis
5.4.2. Rheumatoid arthritis
5.4.3. Others
Chapter 6. Global Cyclooxygenase2 inhibitor Market, by Type
6.1. Market Snapshot
6.2. Global Cyclooxygenase2 inhibitor Market by Type, Performance – Potential Analysis
6.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
6.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
6.4.1. Selective cox 2 inhibitor
6.4.2. Non-selective cox 2 inhibitor
Chapter 7. Global Cyclooxygenase2 inhibitor Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Cyclooxygenase2 inhibitor Market by Route of Administration, Performance – Potential Analysis
7.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by Route of Administration 2016-2026 (USD Billion)
7.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Parenteral
7.4.3. Others
Chapter 8. Global Cyclooxygenase2 inhibitor Market, by End-Users
8.1. Market Snapshot
8.2. Global Cyclooxygenase2 inhibitor Market by End-Users, Performance – Potential Analysis
8.3. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts by End-Users 2016-2026 (USD Billion)
8.4. Global Cyclooxygenase2 inhibitor Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Specialty Clinics
8.4.3. Others
Chapter 9. Global Cyclooxygenase2 inhibitor Market, Regional Analysis
9.1. Global Cyclooxygenase2 inhibitor Market, Regional Market Snapshot
9.2. North America Global Cyclooxygenase2 inhibitor Market
9.2.1. U.S. Global Cyclooxygenase2 inhibitor Market
9.2.1.1. Indication breakdown estimates & forecasts, 2016-2026
9.2.1.2. Type breakdown estimates & forecasts, 2016-2026
9.2.1.3. Route of Administration breakdown estimates & forecasts, 2016-2026
9.2.1.4. End-Users Channel breakdown estimates & forecasts, 2016-2026
9.2.2. Canada Global Cyclooxygenase2 inhibitor Market
9.3. Europe Global Cyclooxygenase2 inhibitor Market Snapshot
9.3.1. U.K. Global Cyclooxygenase2 inhibitor Market
9.3.2. Germany Global Cyclooxygenase2 inhibitor Market
9.3.3. Rest of Europe Global Cyclooxygenase2 inhibitor Market
9.4. Asia-Pacific Global Cyclooxygenase2 inhibitor Market Snapshot
9.4.1. China Global Cyclooxygenase2 inhibitor Market
9.4.2. India Global Cyclooxygenase2 inhibitor Market
9.4.3. Japan Global Cyclooxygenase2 inhibitor Market
9.4.4. Rest of Asia Pacific Global Cyclooxygenase2 inhibitor Market
9.5. Latin America Global Cyclooxygenase2 inhibitor Market Snapshot
9.5.1. Brazil Global Cyclooxygenase2 inhibitor Market
9.5.2. Mexico Global Cyclooxygenase2 inhibitor Market
9.6. Rest of The World Global Cyclooxygenase2 inhibitor Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Indication Summary
10.2.1.5. Recent Developments
10.2.2. Bayer AG
10.2.3. Novartis AG
10.2.4. Sabinsa
10.2.5. Cadila Pharmaceuticals
10.2.6. Mylan N.V.
10.2.7. Teva Pharmaceutical Industries Ltd.
10.2.8. Alembic Pharmaceuticals Limited
10.2.9. Aurobindo Pharma
10.2.10. Cipla Inc.
10.2.11. Torrent Pharmaceuticals Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

TABLE 1. List Of Secondary Sources, Used In The Study Of Global Cyclooxygenase2 inhibitor Market
TABLE 2. List Of Primary Sources, Used In The Study Of Global Cyclooxygenase2 inhibitor Market
TABLE 3. Global Cyclooxygenase2 inhibitor Market, Report Scope
TABLE 4. Years Considered For The Study
TABLE 5. Exchange Rates Considered
TABLE 6. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Region 2016-2026 (USD Billion)
TABLE 7. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Indication 2016-2026 (USD Billion)
TABLE 8. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Type 2016-2026 (USD Billion)
TABLE 9. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Route of Administration 2016-2026 (USD Billion)
TABLE 10. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By End-Users 2016-2026 (USD Billion)
TABLE 11. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 12. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 13. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 14. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 15. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 16. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 17. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 18. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 19. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 20. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 21. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 22. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 23. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 24. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 25. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 26. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 27. Global Cyclooxygenase2 inhibitor Market By Segment, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 28. Global Cyclooxygenase2 inhibitor Market By Region, Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 29. U.S. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 30. U.S. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 31. U.S. Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 32. Canada Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 33. Canada Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 34. Canada Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 35. Uk Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 36. Uk Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 37. Uk Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 38. Germany Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 39. Germany Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 40. Germany Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 41. Roe Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 42. Roe Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 43. Roe Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 44. China Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 45. China Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 46. China Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 47. India Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 48. India Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 49. India Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 50. Japan Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 51. Japan Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 52. Japan Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 53. Roapac Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 54. Roapac Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 55. Roapac Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 56. Brazil Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 57. Brazil Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 58. Brazil Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 59. Mexico Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 60. Mexico Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 61. Mexico Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 62. Rola Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 63. Rola Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 64. Rola Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 65. Row Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts, 2016-2026 (USD Billion)
TABLE 66. Row Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)
TABLE 67. Row Global Cyclooxygenase2 inhibitor Market Estimates & Forecasts By Segment 2016-2026 (USD Billion)

FIG 1. Global Cyclooxygenase2 inhibitor Market, Research Methodology
FIG 2. Global Cyclooxygenase2 inhibitor Market, Market Estimation Techniques
FIG 3. Global Market Size Estimates & Forecast Methods
FIG 4. Global Cyclooxygenase2 inhibitor Market, Key Trends 2019
FIG 5. Global Cyclooxygenase2 inhibitor Market, Growth Prospects 2020-2026
FIG 6. Global Cyclooxygenase2 inhibitor Market, Porters 5 Force Model
FIG 7. Global Cyclooxygenase2 inhibitor Market, Pest Analysis
FIG 8. Global Cyclooxygenase2 inhibitor Market, Value Chain Analysis
FIG 9. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
FIG 10. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
FIG 11. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
FIG 12. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
FIG 13. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
FIG 14. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
FIG 15. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
FIG 16. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
FIG 17. Global Cyclooxygenase2 inhibitor Market By Segment, 2016 & 2026 (USD Billion)
FIG 18. Global Cyclooxygenase2 inhibitor Market, Regional Snapshot 2016 & 2026
FIG 19. North America Global Cyclooxygenase2 inhibitor Market 2016 & 2026 (USD Billion)
FIG 20. Europe Global Cyclooxygenase2 inhibitor Market 2016 & 2026 (USD Billion)
FIG 21. Asia Pacific Global Cyclooxygenase2 inhibitor Market 2016 & 2026 (USD Billion)
FIG 22. Latin America Global Cyclooxygenase2 inhibitor Market 2016 & 2026 (USD Billion)
FIG 23. Global Cyclooxygenase2 inhibitor Market, Company Market Share Analysis (2019)














【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のシクロオキシゲナーゼ2阻害剤市場2020-2026:疾患別(変形性関節症、関節リウマチ、その他)、種類別、投与経路別、エンドユーザー別、流通チャンネル別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆